Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
United Laboratories International Holdings Ltd
3933The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules. It also provides intermediate products, such as 6-aminopenicillanic acid, tert-octylammonium clavulanate, anhydrous sodium carbonate sterile, and penicillin G potassium first crystal. In addition, the company manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products, as well as offers management services. It has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong. Address: 6 Fuk Wang Street, Yuen Long, Hong Kong
Analytics
Precio Objetivo de WallStreet
90.93 HKDRelación P/E
5.8613Rentabilidad por dividendo
7.47 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 3933
Análisis de dividendos 3933
Aumento del dividendo durante 5 años
363 %Crecimiento continuo
5 añosRatio de pago medio en 5 años
20 %Tendencia del payout 3933
Valoración de la acción 3933
Finanzas 3933
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |